ACS Webinar focuses on drug discovery process for small molecule therapeutics

WASHINGTON, April 29, 2010 — News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars™, focusing on professional growth and development.

Scheduled for Thursday, May 6, 2 – 3 p.m. EDT, the free ACS Webinars™ will feature Ann Newman, Ph.D., of Seventh Street Development Group, specializing in solid state and pharmaceutical services consulting and training., speaking on “From a Beaker to a Bottle: Overview of the Drug Discovery and Development Process for Small Molecule Therapeutics.

The ACS Webinars™ connect you with subject experts and global thought leaders in chemical sciences, management, and business to addresses current topics of interest to scientific and engineering professionals. Each webinar includes a short presentation followed by a Q & A session.

News media and scientists can tune into the conference without charge, but must register in advance.

Newman’s topics will include:

  • The complex scientific and regulatory process needed to get a new drug on the market
  • How long it takes, how much it costs, and the odds of getting one new drug approved
  • The animal trials, clinical trials, and human volunteers needed to test a new drug
  • How generic drugs are approved and the role of patents in the regulatory process

Newman has more than 20 years of large pharma and contract research experience. She received her Ph.D. in chemistry from the University of Connecticut and then performed characterization studies on a wide range of pharmaceutical systems at Bristol-Meyers Squibb, covering drug substance and product scale-up from late drug discovery to launch and manufacturing. She later became vice president of Materials Science at SSCI, Inc., and then served as vice president of R&D at Aptuit. Newman holds an adjunct faculty position in industrial and physical pharmacy at Purdue University, and is an author/collaborator of more than 100 articles, book chapters and scientific presentations.


Media Contact:

Michael Bernstein

Michael Woods